March 08, 2021
Article
The complete data from the SURPASS-2 study will be presented during the upcoming American Diabetes Association’s 81st Scientific Sessions.
June 29, 2020
Article
Many tools are becoming available to physicians who need to strengthen their reach of care outside the office.
April 14, 2020
Article
New research shows teprotumumab can be a beneficial treatment for patients suffering from thyroid eye disease (TED), even across age, gender and risk factor-based subgroups. In an interview with HCPLive®, Raymond Douglas, MD, PhD, director of the Orbital and Thyroid Eye Disease Center at the Cedars-Sinai Medical Center, explained the importance of the teprotumumab in treating this patient group and how the coronavirus disease 2019 (COVID-19) might impact thyroid eye disease patients.